Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05354206 · ClinicalTrials.gov registry record · NA

Neural Facilitation of Movements in People With SCI

A NA study, sponsored by Washington University School of Medicine.

Terminated
Registry status
NA
Development phase
20
Enrollment target

NCT05354206: Clinical Trial NA study, sponsored by Washington University School of Medicine.

NCT05354206 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05354206, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.

TERMINATED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

Spinal cord injury leads to long-lasting paralysis and impairment. Re-enabling movement of paralyzed areas is challenging and more information is needed about neurological recovery. The purpose of this study is to understand the contribution of individual neural tracts to movements facilitated by transcutaneous spinal cord stimulation (SCS).

Primary Outcome

This primary outcome is a measure of changes in corticospinal tract excitability as quantified by changes in the amplitude size of motor evoked potentials. Data for this arm were not collected due to early study termination.

Interventions

  • OTHER Electrophysiology assessment - corticospinal tract
  • OTHER Electrophysiology assessment - reticulospinal tract
  • OTHER Training with some stimulation

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2022-06-23
Est. Completion 2023-03-06
Phase NA

Why NCT05354206 stopped before completion

NCT05354206 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 3 interventions - of which Electrophysiology assessment - corticospinal tract is the first listed.

NCT05354206 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05354206 about?

NCT05354206 is a clinical study titled "Neural Facilitation of Movements in People With SCI". Spinal cord injury leads to long-lasting paralysis and impairment. Re-enabling movement of paralyzed areas is challenging and more information is needed about neurological recovery. The purpose of this study is to understand the contribution of individual neural tracts to movements facilitated by tr...

What is the current status of trial NCT05354206?

This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2022-06-23. Estimated completion is 2023-03-06.

What interventions are being tested in trial NCT05354206?

The interventions under investigation include: Electrophysiology assessment - corticospinal tract (OTHER), Electrophysiology assessment - reticulospinal tract (OTHER), Training with some stimulation (OTHER).

Who is sponsoring clinical trial NCT05354206?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05354206's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05354206, the US trial registry maintained by the National Library of Medicine. NCT05354206 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.